vs
Side-by-side financial comparison of Applied Digital Corp. (APLD) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Applied Digital Corp. is the larger business by last-quarter revenue ($126.6M vs $103.7M, roughly 1.2× Twist Bioscience Corp). Applied Digital Corp. runs the higher net margin — -11.4% vs -29.4%, a 18.0% gap on every dollar of revenue. On growth, Applied Digital Corp. posted the faster year-over-year revenue change (98.2% vs 16.9%). Twist Bioscience Corp produced more free cash flow last quarter ($-34.8M vs $-567.9M).
BAE Systems Digital Intelligence is an international defence and security technology firm owned by BAE Systems. They specialize in delivering digital solutions that enable rapid, data-driven decision-making. Their services, solutions and products span customers in Law Enforcement, National Security, Government Departments and Government Enterprises, Critical National Infrastructure, Telecommunications, the Military, and Space.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
APLD vs TWST — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $126.6M | $103.7M |
| Net Profit | $-14.4M | $-30.5M |
| Gross Margin | 20.6% | 52.0% |
| Operating Margin | -24.5% | -31.7% |
| Net Margin | -11.4% | -29.4% |
| Revenue YoY | 98.2% | 16.9% |
| Net Profit YoY | 89.6% | 3.4% |
| EPS (diluted) | $-0.07 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $126.6M | $103.7M | ||
| Q3 25 | $64.2M | — | ||
| Q2 25 | $-33.3M | — | ||
| Q1 25 | $52.9M | — | ||
| Q4 24 | $63.9M | — | ||
| Q3 24 | $60.7M | — | ||
| Q2 24 | $43.7M | — | ||
| Q1 24 | $43.3M | — |
| Q4 25 | $-14.4M | $-30.5M | ||
| Q3 25 | $-16.9M | — | ||
| Q2 25 | $-52.5M | — | ||
| Q1 25 | $-35.6M | — | ||
| Q4 24 | $-138.7M | — | ||
| Q3 24 | $-4.2M | — | ||
| Q2 24 | $-64.5M | — | ||
| Q1 24 | $-62.8M | — |
| Q4 25 | 20.6% | 52.0% | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | -9.1% | — | ||
| Q1 24 | -8.6% | — |
| Q4 25 | -24.5% | -31.7% | ||
| Q3 25 | -34.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -35.8% | — | ||
| Q4 24 | -29.1% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | -68.4% | — | ||
| Q1 24 | -128.8% | — |
| Q4 25 | -11.4% | -29.4% | ||
| Q3 25 | -26.4% | — | ||
| Q2 25 | 157.8% | — | ||
| Q1 25 | -67.2% | — | ||
| Q4 24 | -217.2% | — | ||
| Q3 24 | -7.0% | — | ||
| Q2 24 | -147.5% | — | ||
| Q1 24 | -145.0% | — |
| Q4 25 | $-0.07 | $-0.50 | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-0.31 | — | ||
| Q1 25 | $-0.16 | — | ||
| Q4 24 | $-0.66 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.57 | — | ||
| Q1 24 | $-0.52 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $197.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $456.1M |
| Total Assets | $5.2B | $638.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $197.9M | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | $41.6M | — | ||
| Q1 25 | $68.7M | — | ||
| Q4 24 | $286.2M | — | ||
| Q3 24 | $58.2M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $4.4M | — |
| Q4 25 | $1.4B | $456.1M | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $497.7M | — | ||
| Q1 25 | $454.6M | — | ||
| Q4 24 | $434.6M | — | ||
| Q3 24 | $241.8M | — | ||
| Q2 24 | $124.8M | — | ||
| Q1 24 | $118.5M | — |
| Q4 25 | $5.2B | $638.1M | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $937.7M | — | ||
| Q2 24 | $762.9M | — | ||
| Q1 24 | $643.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.8M | $-24.8M |
| Free Cash FlowOCF − Capex | $-567.9M | $-34.8M |
| FCF MarginFCF / Revenue | -448.6% | -33.5% |
| Capex IntensityCapex / Revenue | 436.1% | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.3B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.8M | $-24.8M | ||
| Q3 25 | $-82.0M | — | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $5.9M | — | ||
| Q4 24 | $-52.3M | — | ||
| Q3 24 | $-75.9M | — | ||
| Q2 24 | $-34.1M | — | ||
| Q1 24 | $38.8M | — |
| Q4 25 | $-567.9M | $-34.8M | ||
| Q3 25 | $-331.4M | — | ||
| Q2 25 | $-191.4M | — | ||
| Q1 25 | $-251.6M | — | ||
| Q4 24 | $-223.3M | — | ||
| Q3 24 | $-130.7M | — | ||
| Q2 24 | $-88.9M | — | ||
| Q1 24 | $-2.3M | — |
| Q4 25 | -448.6% | -33.5% | ||
| Q3 25 | -516.1% | — | ||
| Q2 25 | 574.8% | — | ||
| Q1 25 | -475.4% | — | ||
| Q4 24 | -349.6% | — | ||
| Q3 24 | -215.3% | — | ||
| Q2 24 | -203.5% | — | ||
| Q1 24 | -5.4% | — |
| Q4 25 | 436.1% | 9.6% | ||
| Q3 25 | 388.4% | — | ||
| Q2 25 | -595.4% | — | ||
| Q1 25 | 486.6% | — | ||
| Q4 24 | 267.8% | — | ||
| Q3 24 | 90.3% | — | ||
| Q2 24 | 125.4% | — | ||
| Q1 24 | 95.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APLD
| HPC Hosting Business | $85.0M | 67% |
| Data Center Hosting Business | $41.6M | 33% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
